“…Beta cell function deteriorates faster than in type 2 diabetes but slower than in type 1 diabetes [1,5,13,16], and there is no difference in hepatic or peripheral insulin sensitivity between type 1, type 2 and LADA, whether in the diabetic [3] or the prediabetic [17] state. Nevertheless, patients with LADA have fewer features of the metabolic syndrome than patients with type 2 diabetes [6,18], and have fewer macrovascular complications [18].…”